{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:07:39Z","timestamp":1793502459496,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"ANR France","award":["ANR-14-CE15-0001-MECANO"],"award-info":[{"award-number":["ANR-14-CE15-0001-MECANO"]}]},{"name":"ANR France","award":["ANR-18-RHUS-0012-BETPSY"],"award-info":[{"award-number":["ANR-18-RHUS-0012-BETPSY"]}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"crossref","award":["DQ20170336751"],"award-info":[{"award-number":["DQ20170336751"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008052","name":"Fundaci\u00f3n Alfonso Mart\u00edn Escudero","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s00415-020-09782-8","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T10:02:43Z","timestamp":1583748163000},"page":"1906-1911","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Primary DQ effect in the association between HLA and neurological syndromes with anti-GAD65 antibodies"],"prefix":"10.1007","volume":"267","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5958-3288","authenticated-orcid":false,"given":"Sergio","family":"Mu\u00f1iz-Castrillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Ambati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Vogrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastien","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Rogemond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Fabien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Mignot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Honnorat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,9]]},"reference":[{"key":"9782_CR1","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1093\/brain\/awn183","volume":"131","author":"A Saiz","year":"2008","unstructured":"Saiz A, Blanco Y, Sabater L et al (2008) Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 131:2553\u20132563. https:\/\/doi.org\/10.1093\/brain\/awn183","journal-title":"Brain"},{"key":"9782_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1001\/archneur.58.2.225","volume":"58","author":"J Honnorat","year":"2001","unstructured":"Honnorat J, Saiz A, Giometto B et al (2001) Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol 58:225\u2013230. https:\/\/doi.org\/10.1001\/archneur.58.2.225","journal-title":"Arch Neurol"},{"key":"9782_CR3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1684\/epd.2013.0607","volume":"15","author":"ME Garc\u00eda Garc\u00eda","year":"2013","unstructured":"Garc\u00eda Garc\u00eda ME, Castrillo SM, Morales IG et al (2013) Acute amnesia and seizures in a young female. Epileptic Disord 15:455\u2013460. https:\/\/doi.org\/10.1684\/epd.2013.0607","journal-title":"Epileptic Disord"},{"key":"9782_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.21050","volume":"61","author":"J Dalmau","year":"2007","unstructured":"Dalmau J, T\u00fcz\u00fcn E, Wu H et al (2007) Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61:25\u201336. https:\/\/doi.org\/10.1002\/ana.21050","journal-title":"Ann Neurol"},{"key":"9782_CR5","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1474-4422(18)30244-8","volume":"17","author":"T Armangue","year":"2018","unstructured":"Armangue T, Spatola M, Vlagea A et al (2018) Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol 17:760\u2013772. https:\/\/doi.org\/10.1016\/S1474-4422(18)30244-8","journal-title":"Lancet Neurol"},{"key":"9782_CR6","doi-asserted-by":"publisher","first-page":"e0121364","DOI":"10.1371\/journal.pone.0121364","volume":"10","author":"N Gresa-Arribas","year":"2015","unstructured":"Gresa-Arribas N, Ari\u00f1o H, Mart\u00ednez-Hern\u00e1ndez E et al (2015) Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity. PLoS ONE 10:e0121364. https:\/\/doi.org\/10.1371\/journal.pone.0121364","journal-title":"PLoS ONE"},{"key":"9782_CR7","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1212\/01.wnl.0000092016.98256.21","volume":"61","author":"TM Burns","year":"2003","unstructured":"Burns TM, Jones HR, Phillips LH et al (2003) Clinically disparate stiff-person syndrome with GAD65 autoantibody in a father and daughter. Neurology 61:1291\u20131293. https:\/\/doi.org\/10.1212\/01.wnl.0000092016.98256.21","journal-title":"Neurology"},{"key":"9782_CR8","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1016\/j.clinph.2015.03.010","volume":"126","author":"Z Xiao","year":"2015","unstructured":"Xiao Z, Shan J, Huang X et al (2015) Familial case reports of stiff-person syndrome. Clin Neurophysiol 126:2408\u20132409. https:\/\/doi.org\/10.1016\/j.clinph.2015.03.010","journal-title":"Clin Neurophysiol"},{"key":"9782_CR9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1159\/000369784","volume":"6","author":"J Kuchling","year":"2014","unstructured":"Kuchling J, Shababi-Klein J, N\u00fcmann A et al (2014) GAD antibody-associated late-onset cerebellar ataxia in two female siblings. Case Rep Neurol 6:264\u2013270. https:\/\/doi.org\/10.1159\/000369784","journal-title":"Case Rep Neurol"},{"key":"9782_CR10","doi-asserted-by":"publisher","first-page":"e416","DOI":"10.1212\/NXI.0000000000000416","volume":"5","author":"A Belbezier","year":"2018","unstructured":"Belbezier A, Joubert B, Montero-Martin G et al (2018) Multiplex family with GAD65-Abs neurologic syndromes. Neurol Neuroimmunol Neuroinflamm 5:e416. https:\/\/doi.org\/10.1212\/NXI.0000000000000416","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"9782_CR11","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1210\/jcem.77.6.8263140","volume":"77","author":"A Pugliese","year":"1993","unstructured":"Pugliese A, Solimena M, Awdeh ZL et al (1993) Association of HLA-DQB1*0201 with stiff-man syndrome. J Clin Endocrinol Metab 77:1550\u20131553. https:\/\/doi.org\/10.1210\/jcem.77.6.8263140","journal-title":"J Clin Endocrinol Metab"},{"key":"9782_CR12","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1212\/wnl.55.10.1531","volume":"55","author":"MC Dalakas","year":"2000","unstructured":"Dalakas MC, Fujii M, Li M, McElroy B (2000) The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology 55:1531\u20131535. https:\/\/doi.org\/10.1212\/wnl.55.10.1531","journal-title":"Neurology"},{"key":"9782_CR13","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1046\/j.1365-2249.2002.01931.x","volume":"129","author":"M Costa","year":"2002","unstructured":"Costa M, Saiz A, Casamitjana R et al (2002) T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity. Clin Exp Immunol 129:471\u2013478. https:\/\/doi.org\/10.1046\/j.1365-2249.2002.01931.x","journal-title":"Clin Exp Immunol"},{"key":"9782_CR14","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1056\/NEJM200009073431006","volume":"343","author":"J Klein","year":"2000","unstructured":"Klein J, Sato A (2000) The HLA system. N Engl J Med 343:702\u2013709. https:\/\/doi.org\/10.1056\/NEJM200009073431006","journal-title":"N Engl J Med"},{"key":"9782_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jaut.2015.06.010","volume":"64","author":"JA Hollenbach","year":"2015","unstructured":"Hollenbach JA, Oksenberg JR (2015) The immunogenetics of multiple sclerosis: a comprehensive review. J Autoimmun 64:13\u201325. https:\/\/doi.org\/10.1016\/j.jaut.2015.06.010","journal-title":"J Autoimmun"},{"key":"9782_CR16","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1093\/sleep\/17.suppl_8.s60","volume":"17","author":"E Mignot","year":"1994","unstructured":"Mignot E, Lin X, Arrigoni J et al (1994) DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans. Sleep 17:S60\u201367. https:\/\/doi.org\/10.1093\/sleep\/17.suppl_8.s60","journal-title":"Sleep"},{"key":"9782_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/ana.24860","volume":"81","author":"T-J Kim","year":"2017","unstructured":"Kim T-J, Lee S-T, Moon J et al (2017) Anti-LGI1 encephalitis is associated with unique HLA subtypes: HLA subtypes in anti-LGI1 encephalitis. Ann Neurol 81:183\u2013192. https:\/\/doi.org\/10.1002\/ana.24860","journal-title":"Ann Neurol"},{"key":"9782_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ana.24858","volume":"81","author":"A van Sonderen","year":"2017","unstructured":"van Sonderen A, Roelen DL, Stoop JA et al (2017) Anti-LGI1 encephalitis is strongly associated with HLA-DR7 and HLA-DRB4: anti-LGI1 encephalitis. Ann Neurol 81:193\u2013198. https:\/\/doi.org\/10.1002\/ana.24858","journal-title":"Ann Neurol"},{"key":"9782_CR19","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","volume":"88","author":"C Gaig","year":"2017","unstructured":"Gaig C, Graus F, Compta Y et al (2017) Clinical manifestations of the anti-IgLON5 disease. Neurology 88:1736\u20131743. https:\/\/doi.org\/10.1212\/WNL.0000000000003887","journal-title":"Neurology"},{"key":"9782_CR20","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/tpj.2013.18","volume":"14","author":"X Zheng","year":"2014","unstructured":"Zheng X, Shen J, Cox C et al (2014) HIBAG\u2014HLA genotype imputation with attribute bagging. Pharmacogenom J 14:192\u2013200. https:\/\/doi.org\/10.1038\/tpj.2013.18","journal-title":"Pharmacogenom J"},{"key":"9782_CR21","doi-asserted-by":"publisher","first-page":"e1003880","DOI":"10.1371\/journal.pgen.1003880","volume":"9","author":"F Han","year":"2013","unstructured":"Han F, Faraco J, Dong XS et al (2013) Genome wide analysis of narcolepsy in china implicates novel immune loci and reveals changes in association prior to versus after the 2009 H1N1 influenza pandemic. PLoS Genet 9:e1003880. https:\/\/doi.org\/10.1371\/journal.pgen.1003880","journal-title":"PLoS Genet"},{"key":"9782_CR22","doi-asserted-by":"publisher","first-page":"8676","DOI":"10.1073\/pnas.1206614109","volume":"109","author":"C Wang","year":"2012","unstructured":"Wang C, Krishnakumar S, Wilhelmy J et al (2012) High-throughput, high-fidelity HLA genotyping with deep sequencing. Proc Natl Acad Sci USA 109:8676\u20138681. https:\/\/doi.org\/10.1073\/pnas.1206614109","journal-title":"Proc Natl Acad Sci USA"},{"key":"9782_CR23","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2337\/db07-1331","volume":"57","author":"H Erlich","year":"2008","unstructured":"Erlich H, Valdes AM, Noble J et al (2008) HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 57:1084\u20131092. https:\/\/doi.org\/10.2337\/db07-1331","journal-title":"Diabetes"},{"key":"9782_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.2337\/diabetes.49.1.48","volume":"49","author":"P Kulmala","year":"2000","unstructured":"Kulmala P, Savola K, Reijonen H et al (2000) Genetic markers, humoral autoimmunity, and prediction of type 1 diabetes in siblings of affected children. Childhood Diabetes in Finland Study Group. Diabetes 49:48\u201358. https:\/\/doi.org\/10.2337\/diabetes.49.1.48","journal-title":"Diabetes"},{"key":"9782_CR25","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1007\/s00125-015-3514-y","volume":"58","author":"JP Krischer","year":"2015","unstructured":"The TEDDY Study Group, Krischer JP, Lynch KF et al (2015) The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: The TEDDY Study. Diabetologia 58:980\u2013987. https:\/\/doi.org\/10.1007\/s00125-015-3514-y","journal-title":"Diabetologia"},{"key":"9782_CR26","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1046\/j.1464-5491.2000.00354.x","volume":"17","author":"CEM De Block","year":"2000","unstructured":"De Block CEM, De Leeuw IH, Rooman RPA et al (2000) Gastric parietal cell antibodies are associated with glutamic acid decarboxylase-65 antibodies and the HLA DQA1*0501\u2013DQB1*0301 haplotype in Type 1 diabetes mellitus. Diabet Med 17:618\u2013622. https:\/\/doi.org\/10.1046\/j.1464-5491.2000.00354.x","journal-title":"Diabet Med"},{"key":"9782_CR27","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.2337\/db11-0131","volume":"60","author":"JMM Howson","year":"2011","unstructured":"Howson JMM, Stevens H, Smyth DJ et al (2011) Evidence that HLA Class I and II associations with type 1 diabetes, autoantibodies to GAD and autoantibodies to IA-2, are distinct. Diabetes 60:2635\u20132644. https:\/\/doi.org\/10.2337\/db11-0131","journal-title":"Diabetes"},{"key":"9782_CR28","doi-asserted-by":"publisher","first-page":"e000076","DOI":"10.1136\/bmjdrc-2014-000076","volume":"3","author":"EP S\u00f8rgjerd","year":"2015","unstructured":"S\u00f8rgjerd EP, Thorsby PM, Torjesen PA et al (2015) Presence of anti-GAD in a non-diabetic population of adults; time dynamics and clinical influence: results from the HUNT study. BMJ Open Diabetes Res Care 3:e000076. https:\/\/doi.org\/10.1136\/bmjdrc-2014-000076","journal-title":"BMJ Open Diabetes Res Care"},{"key":"9782_CR29","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1007\/s00125-014-3294-9","volume":"57","author":"C Bender","year":"2014","unstructured":"Bender C, Schlosser M, Christen U et al (2014) GAD autoantibody affinity in schoolchildren from the general population. Diabetologia 57:1911\u20131918. https:\/\/doi.org\/10.1007\/s00125-014-3294-9","journal-title":"Diabetologia"},{"key":"9782_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/cei.13115","volume":"192","author":"A Kozhakhmetova","year":"2018","unstructured":"Kozhakhmetova A, Wyatt RC, Caygill C et al (2018) A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family study: multiple autoimmunity in type 1 diabetes. Clin Exp Immunol 192:251\u2013258. https:\/\/doi.org\/10.1111\/cei.13115","journal-title":"Clin Exp Immunol"},{"key":"9782_CR31","first-page":"221","volume":"71","author":"BO Boehm","year":"1993","unstructured":"Boehm BO, K\u00fchnl P, L\u00f6liger C et al (1993) HLA-DR3 and HLA-DR5 confer risk for autoantibody positivity against the thyroperoxidase (mic-TPO) antigen in healthy blood donors. Clin Investig 71:221\u2013225","journal-title":"Clin Investig"},{"key":"9782_CR32","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2337\/diab.43.1.80","volume":"43","author":"E Kawasaki","year":"1994","unstructured":"Kawasaki E, Takino H, Yano M et al (1994) Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 43:80\u201386. https:\/\/doi.org\/10.2337\/diab.43.1.80","journal-title":"Diabetes"},{"key":"9782_CR33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1046\/j.1365-2249.1999.00945.x","volume":"117","author":"F Rharbaoui","year":"1999","unstructured":"Rharbaoui F, Mayer A, Granier C et al (1999) T cell response pattern to glutamic acid decarboxylase 65 (GAD65) peptides of newly diagnosed type 1 diabetic patients sharing susceptible HLA haplotypes. Clin Exp Immunol 117:30\u201337. https:\/\/doi.org\/10.1046\/j.1365-2249.1999.00945.x","journal-title":"Clin Exp Immunol"},{"key":"9782_CR34","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.4049\/jimmunol.163.11.6275","volume":"163","author":"AE Herman","year":"1999","unstructured":"Herman AE, Tisch RM, Patel SD et al (1999) Determination of glutamic acid decarboxylase 65 peptides presented by the type I diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide motif. J Immunol 163:6275\u20136282","journal-title":"J Immunol"},{"key":"9782_CR35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/imm.12034","volume":"138","author":"J Yang","year":"2013","unstructured":"Yang J, James EA, Sanda S et al (2013) CD4+ T cells recognize diverse epitopes within GAD65: implications for repertoire development and diabetes monitoring. Immunology 138:269\u2013279. https:\/\/doi.org\/10.1111\/imm.12034","journal-title":"Immunology"},{"key":"9782_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2016.09.007","volume":"76","author":"CW Li","year":"2017","unstructured":"Li CW, Osman R, Menconi F et al (2017) Flexible peptide recognition by HLA-DR triggers specific autoimmune T-cell responses in autoimmune thyroiditis and diabetes. J Autoimmun 76:1\u20139. https:\/\/doi.org\/10.1016\/j.jaut.2016.09.007","journal-title":"J Autoimmun"},{"key":"9782_CR37","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.2337\/db10-0076","volume":"59","author":"F Pociot","year":"2010","unstructured":"Pociot F, Akolkar B, Concannon P et al (2010) Genetics of type 1 diabetes: what\u2019s next? Diabetes 59:1561\u20131571. https:\/\/doi.org\/10.2337\/db10-0076","journal-title":"Diabetes"},{"key":"9782_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fgene.2016.00003","volume":"7","author":"C Shen","year":"2016","unstructured":"Shen C, Gao J, Sheng Y et al (2016) Genetic susceptibility to vitiligo: GWAS approaches for identifying vitiligo susceptibility genes and loci. Front Genet 7:3. https:\/\/doi.org\/10.3389\/fgene.2016.00003","journal-title":"Front Genet"},{"key":"9782_CR39","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrendo.2013.56","volume":"9","author":"MJ Simmonds","year":"2013","unstructured":"Simmonds MJ (2013) GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis. Nat Rev Endocrinol 9:277\u2013287. https:\/\/doi.org\/10.1038\/nrendo.2013.56","journal-title":"Nat Rev Endocrinol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09782-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-020-09782-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09782-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T06:27:38Z","timestamp":1695882458000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-020-09782-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,9]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["9782"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-09782-8","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,9]]},"assertion":[{"value":"28 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.\u00a0","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures were performed in accordance with the institutional ethics committee and the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}